Table 1.
Clinical characteristics of sample (n=56)
| Variables | All participants (n=56) | NHW (n=31) | HW (n=25) | |
|---|---|---|---|---|
| Gender | ||||
| M | 31 (55%) | 14 (45%) | 17 (68%) | |
| F | 25 (45%) | 17 (55%) | 8 (32%) | |
| Occupation | ||||
| Working | 54% | 50% | 58% | |
| Retired | 17% | 17% | 17% | |
| Handicapped | 8% | 8% | 8% | |
| Chemotherapy | ||||
| 5FU | 54% | 50% | 58% | |
| Xeloda | 42% | 42% | 42% | |
| Mean (SD) | Mean (SD) | Mean (SD) | p-value | |
| Age | 60.5 (13.1) | 59.1 (12.4) | 62.4 (14.1) | 0.34 |
| Education | 13.3 (3.0) | 13.8 (2.6) | 12.5 (3.6) | 0.56 |
| # treatment | 28.7 (3.7) | 29.0 (3.5) | 27.8 (4.1) | 0.43 |
| BMI | 27.1 (5.1) | 27.6 (4.6) | 26.0 (6.3) | 0.55 |